Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with Schedule III of the Listing Regulations, Fortis Healthcare has informed about the following changes in the composition of the Board: (a) Based on the recommendation of the Nomination and Remuneration Committee of the Company, the Board of Directors of the Company through circular resolution passed today, i.e. December 19, 2025 had approved the appointment of Mohd Shahazwan Bin Mohd Harris (DIN: 08465456) as an Additional Director (Non-Executive & Non-Independent) of the Company effective from December 19, 2025. Mohd Shahazwan Bin Mohd Harris is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other authority. The date and time of occurrence of event is December 19, 2025 at 09.01 AM (IST); (b) Lim Tsin Lin (DIN: 10118906) had resigned from the position of Non-Executive & Non-Independent Director of the Company and accordingly, ceased to be Director of the Company effective from December 19, 2025 (close of business hours). The resignation letter of Lim Tsin Lin is enclosed as Annexure -A. The detailed disclosure as required under Regulation 30 of the Listing Regulations read with Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as Annexure-B. The date and time of occurrence of event is December 19, 2025 at 01.23 pm (IST).